ARCA Discovery, Inc., (Denver,CO) a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced that Richard B. Brewer has been appointed President and CEO. Prior to ARCA Discovery Mr. Brewer was managing partner at Crest Asset Management, previously, Mr. Brewer was president and CEO of Scios, Inc. (NYSE: JNJ), served as [...]

• 136http://clsdf.com/2006/11/arca-discovery-names-ceo/ARCA+Discovery%3A+Names+CEO2006-11-10+18%3A33%3A00admin

We can thank the Tufts Center for the Study of Drug Development for officially estimating the cost to bring a biotech product to market, that is $1.2B, with average preclinical costs of $615M and clinical costs of $626M, and requires just over eight years to bring to market. Note: Average out-of-pocket cost per approved biopharmaceutical [...]

• 135http://clsdf.com/2006/11/data-data-data/Data+Data+Data...2006-11-10+17%3A54%3A00admin